检索结果 - Thomas Powles

Refine Results
  1. 1
    Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancer

    Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancer 由 Thomas Powles

    出版 2020
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  2. 2
    Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic

    Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic 由 Silke Gillessen, Thomas Powles

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now

    A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now 由 J Bellmunt, Thomas Powles, Nicholas J. Vogelzang

    出版 2017
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    The evolving role of PD-L1 testing in patients with metastatic urothelial carcinoma

    The evolving role of PD-L1 testing in patients with metastatic urothelial carcinoma 由 Thomas Powles, Jill Walker, J. Andrew Williams, Joaquim Bellmunt

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    The cancer-immunity cycle: Indication, genotype, and immunotype

    The cancer-immunity cycle: Indication, genotype, and immunotype 由 Ira Mellman, Daniel S. Chen, Thomas Powles, Shannon J. Turley

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Is High Dose Therapy Superior to Conventional Dose Therapy as Initial Treatment for Relapsed Germ Cell Tumors? The TIGER Trial

    Is High Dose Therapy Superior to Conventional Dose Therapy as Initial Treatment for Relapsed Germ Cell Tumors? The TIGER Trial 由 Darren R. Feldman, Robert Huddart, Emma Hall, J. Beyer, Thomas Powles

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma

    Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma 由 Robert J. Motzer, Bernard Escudier, Thomas Powles, Christian Scheffold, Toni K. Choueiri

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Rise of Antibody-Drug Conjugates: The Present and Future

    Rise of Antibody-Drug Conjugates: The Present and Future 由 Mythili Shastry, Avantika Gupta, Sarat Chandarlapaty, Matthew R. Young, Thomas Powles, Erika Hamilton

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis

    The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis 由 Thomas Powles, David Robinson, Jonathan Shamash, Henrik Møller, N. L. Tranter, R.T.D. Oliver

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches

    Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches 由 Dongkui Song, Thomas Powles, Lei Shi, Lirong Zhang, Molly A. Ingersoll, Yong‐Jie Lu

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events

    Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events 由 Viktor Grünwald, Martin H. Voss, Brian I. Rini, Thomas Powles, Laurence Albigès, Rachel H. Giles, Eric Jonasch

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  12. 12
    Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection

    Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection 由 Thomas Powles, David Robinson, Justin Stebbing, Jonathan Shamash, Mark Nelson, Brian Gazzard, Sundhiya Mandelia, Henrik Møller, Mark Bower

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib

    Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib 由 Jonathan Welti, Morgane Gourlaouen, Thomas Powles, Sakunthala C. Kudahetti, Paul A. Wilson, Daniel M. Berney, Andrew R. Reynolds

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer

    The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer 由 Nick van Dijk, Samuel A. Funt, Christian U. Blank, Thomas Powles, Jonathan E. Rosenberg, Michiel S. van der Heijden

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  15. 15
    Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway

    Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway 由 Thomas Powles, Robert te Poele, Jonathan Shamash, Tracy Chaplin, David Propper, Simon Joel, R.T.D. Oliver, Wai M. Liu

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma

    ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma 由 Thomas Powles, Laurence Albigès, Axel Bex, Viktor Grünwald, Camillo Porta, Giuseppe Procopio, Manuela Schmidinger, Cristina Suárez, Guillermo de Velasco

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Local treatments for metastases of renal cell carcinoma: a systematic review

    Local treatments for metastases of renal cell carcinoma: a systematic review 由 Saeed Dabestani, Lorenzo Marconi, Fabian Hofmann, Fiona Stewart, Thomas Lam, Steven Canfield, Michael Staehler, Thomas Powles, Börje Ljungberg, Axel Bex

    出版 2014
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  18. 18
    Hypothalamo-Pituitary Abnormalities in Adult Patients with Langerhans Cell Histiocytosis: Clinical, Endocrinological, and Radiological Features and Response to Treatment

    Hypothalamo-Pituitary Abnormalities in Adult Patients with Langerhans Cell Histiocytosis: Clinical, Endocrinological, and Radiological Features and Response to Treatment 由 Gregory Kaltsas, Thomas Powles, Jane Evanson, P N Plowman, J. E. Drinkwater, P Jenkins, JP Monson, G. M. Besser, Ashley Grossman

    出版 2000
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patients

    Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patients 由 Thomas Powles, Sergio Bracarda, Chen Mei, Elliot Norry, Natalie Compton, Mark Heise, Thomas E. Hutson, Philipp Harter, Christopher L. Carpenter, Lini Pandite, Neil Kaplowitz

    出版 2015
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  20. 20
    Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma

    Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma 由 Jennifer L. Beaumont, John M. Salsman, Jose Diaz, Keith C. Deen, Lauren McCann, Thomas Powles, Michelle D. Hackshaw, Robert J. Motzer, David Cella

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: